Clinical trial
An Open Label, Comparative, Multi-Center Study, to Evaluate the Efficacy and Safety of Peginterferon Alfa-2a Plus Ribavirin in the Treatment of Patients With Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
NCT00154869 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label, Comparative, Multi-Center Study, to Evaluate the Efficacy and Safety of Peginterferon Alfa-2a Plus Ribavirin in the Treatment of Patients With Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 30, 2004
- Completion date
- August 31, 2007
- Enrollment
- 320 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.